ARID1A and cancer: Another epigenetic regulator frequently dysregulated in UC (18–25%), ARID1A, has not only shown altered signal transduction in other cancers, but also altered cell cycle control, DNA damage repair responses, tumor microenvironment and checkpoint signaling [111].